Meta-Analysis Comparing Potent Oral P2Y(12) Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

BACKGROUND: In patients with atrial fibrillation (AF) receiving percutaneous coronary intervention (PCI), current guidelines recommend against combining potent oral P2Y(12) inhibitors (i.e. ticagrelor or prasugrel) with oral anticoagulant (OAC) therapy, but the evidence is limited. OBJECTIVE: The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Casula, Matteo, Fortuni, Federico, Ferlini, Marco, Fabris, Francesca, Oltrona Visconti, Luigi, Leonardi, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956939/
https://www.ncbi.nlm.nih.gov/pubmed/32895853
http://dx.doi.org/10.1007/s40256-020-00436-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956939/
https://www.ncbi.nlm.nih.gov/pubmed/32895853
http://dx.doi.org/10.1007/s40256-020-00436-8

Ejemplares similares